ESR1 and breast carcinoma: Basal breast cancers harbor high immune infiltrations at least in part due to higher tumor mutation burden (TMB)72, however, we did not detect higher TMB in BCK-high vs. low ER+ tumors (Supplementary Fig. 12i).